Home — Centre for Medicines Discovery (CMD)

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

NDM Research Building

The Centre for Medicines Discovery aims to catalyse the discovery
and development of new medicines for patients.

News

Solute carrier spinster homolog 2 (SPNS2)

The solute carrier SPNS2 recruits PI(4,5)P2 to synergistically regulate transport of sphingosine-1-phosphate

8 August 2023

CDKL5 figure

Discovery of a chemical probe for CDKL5 demonstrates role in hippocampal CA1 physiology

4 August 2023

KEAP1 protein structure

Research reveals basis for KEAP1-CUL3 E3 ligase assembly and inhibition by CDDO

19 May 2023

BIRC6 structure

Research reveals the first molecular understanding of BIRC6 – an essential regulator of cell death

14 February 2023

More news

Publications

Deep topographic proteomics of a human brain tumour.
Journal article

Davis S. et al, (2023), Nat Commun, 14
Stimulating and toxic effect of chromium on growth and photosynthesis of a marine chlorophyte.
Journal article

Zhang Q. et al, (2023), New Phytol
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.
Journal article

Boby ML. et al, (2023), Science, 382

More publications

Research highlights

TREM2 - A TEP for Neuroscience & Neurological Disorders

TREM2: A TEP for Neuroscience & Neurological Disorders

AGR graphic abstract

Human AGR2 Deficiency Causes Mucus Barrier Dysfunction and Infantile Inflammatory Bowel Disease

CDKL5: A TEP for Inflammation and Neuropsychiatry

CDKL5: A TEP for Inflammation and Neuropsychiatry

More highlights